Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CNR2 contributors: mct - updated : 15-12-2021
HGNC name cannabinoid receptor 2 (macrophage)
HGNC id 2160
Location 1p36.11      Physical location : 24.200.460 - 24.239.817
Synonym symbol(s) CB2, CX5, EVI11, CB2R, CB-2
DNA
TYPE functioning gene
STRUCTURE 42.85 kb     2 Exon(s)
Genomic sequence alignment details
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked N status provisional
regionally located located in rhabdomyosarcoma (RMS) breakpoint region
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
- - - 1776 - 360 - 2021 33512770
2 polyA site 5265 - 360 - 2021 33512770
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
blood / hematopoieticspleen    
Lymphoid/Immunelymph node    
Reproductivemale systemtestis    Homo sapiens
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / hematopoietic    
cells
SystemCellPubmedSpeciesStageRna symbol
Lymphoid/Immunemacrophage
Reproductivegerm cell Homo sapiens
ReproductiveLeydig cell Homo sapiens
Skeletonosteoblast
Skeletonosteoclast
cell lineage
  • myeloid cell lines
  • cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
    seven transmembrane segments (7TM) receptor, hematopoietic
    HOMOLOGY
    interspecies homolog to murine Cnr2
    Homologene
    FAMILY family 1 of G protein coupled receptor
    CATEGORY protooncogene , receptor membrane G
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,endoplasmic reticulum
    basic FUNCTION
  • inhibiting adenylate cyclase
  • putatively involved in the initiation of cell maturation
  • playing an essential role for the maintenance of normal bone mass by osteoblastic and osteoclastic signaling
  • CNR2, but not CNR1, regulates embryonic HSC (Hematopoietic Stem Cell) development
  • CNR2-signaling optimizes the production, expansion, and migration of embryonic HSCs by modulating multiple downstream signaling pathways
  • major receptor of endocannabinoid system that is crucial for bone mass homeostasis
  • osteogenic differentiation induced by CNR2 signaling activation involves autophagy induction
  • CNR2 activation can induce neurons proliferation and survival through activation of ERK and MAPK14 signaling pathways
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • upregulating nine genes involved in cytokine synthesis, regulation of transcription, cell differentiation
  • activation of CNR2 could promote the intracellular degradation of HMGB1 via the autophagy-lysosome pathway in macrophage
  • cell & other
    REGULATION
    activated by 2-arachidonoylglycerol
    elevated endogenous levels of endocannabinoids
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional       loss of function
    combined deficiency of the CNR1 and CNR2 receptors protects against age-related bone loss by osteoclast inhibition
    Susceptibility
  • to ostoporosis (low hip BMD)
  • to immune thrombocytopenic purpura
  • Variant & Polymorphism SNP
  • increasing the risk of osteoporosis
  • significant overrepresentation of the RR genotype and of the R allele was observed only for the chronic form of immune thrombocytopenic purpura children
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    osteoarticularbone 
    molecular target for the diagnosis and treatment of osteoporosis and other bone diseases (antagonists of CNR2)
    metabolismlipid 
    pharmacological manipulation of CB2R may provide therapeutic possibilities to treat metabolic diseases associated with lipid dysregulation
    ANIMAL & CELL MODELS
  • extensive cardiomyocyte loss and confluent scar formation were found in Cnr2-/- mice accompanied by significantly increased apoptosis and left ventricular dysfunction when compared with Cnr2 +/+ mice